Provided by Tiger Trade Technology Pte. Ltd.

Oric Pharmaceuticals Inc.

12.07
-0.4300-3.44%
Post-market: 12.070.00000.00%19:30 EDT
Volume:1.03M
Turnover:12.58M
Market Cap:1.25B
PE:-8.93
High:12.79
Open:12.64
Low:12.01
Close:12.50
52wk High:14.93
52wk Low:7.23
Shares:103.52M
Float Shares:88.69M
Volume Ratio:0.84
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3513
EPS(LYR):-1.4747
ROE:-39.80%
ROA:-25.97%
PB:3.28
PE(LYR):-8.18

Loading ...

JonesTrading Sticks to Their Buy Rating for Oric Pharmaceuticals (ORIC)

TIPRANKS
·
Apr 07

Oric Pharma grants 80,000 stock options in Nasdaq Rule 5635(c)(4) inducement award

Reuters
·
Apr 04

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 04

Analysts Offer Insights on Healthcare Companies: Imunon (IMNN), Axsome Therapeutics (AXSM) and Oric Pharmaceuticals (ORIC)

TIPRANKS
·
Apr 02

Oric selloff brings attractive entry point, says H.C. Wainwright

TIPRANKS
·
Apr 02

Oric Pharmaceuticals Down Nearly 39%, on Track for Record Percent Decrease -- Data Talk

Dow Jones
·
Apr 02

Oric Pharmaceuticals should be bought on selloff, says Citi

TIPRANKS
·
Apr 02

Oric Pharmaceuticals price target lowered to $17 from $20 at Wedbush

TIPRANKS
·
Apr 01

Wall Street Set to Open Higher as Trump Says US Will Consider Ceasefire if Hormuz Strait Opened

MT Newswires Live
·
Apr 01

Oric Pharmaceuticals Is Maintained at Outperform by Wedbush

Dow Jones
·
Apr 01

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Diamedica Therapeutics (DMAC), Elevance Health (ELV) and Oric Pharmaceuticals (ORIC)

TIPRANKS
·
Apr 01

Oric Pharmaceuticals (ORIC) Receives a Buy from Evercore ISI

TIPRANKS
·
Apr 01

Top Premarket Decliners

MT Newswires Live
·
Apr 01

Guggenheim Keeps Their Buy Rating on Oric Pharmaceuticals (ORIC)

TIPRANKS
·
Apr 01

Wedbush Cuts Price Target on ORIC Pharmaceuticals to $17 From $20, Keeps Outperform Rating

MT Newswires Live
·
Apr 01

Oric Pharmaceuticals Shares Fall on Side Effect Data in Prostate Cancer Drug Trial

Dow Jones
·
Apr 01

ORIC Pharmaceuticals Stock Nosedives 25% After Hours: What Is Going On?

Benzinga_recent_news
·
Apr 01

Oric Advances Rinzimetostat Toward First Prostate Cancer Phase 3

TIPRANKS
·
Apr 01

24H|DEFT Soared 50%; NCino Surged 20%; Oric Pharmaceuticals Plunged 25%; Battalion Oil Down 9%

Tiger Newspress
·
Apr 01

Oric Pharmaceuticals announces rinzimetostat, ORIC-944, program update

TIPRANKS
·
Apr 01